QIAGEN N.V. (QGEN) Fundamental Analysis & Valuation

NYSE:QGEN • NL0015002SN0

Current stock price

39.93 USD
-0.72 (-1.77%)
At close:
39.93 USD
0 (0%)
After Hours:

This QGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. QGEN Profitability Analysis

1.1 Basic Checks

  • QGEN had positive earnings in the past year.
  • QGEN had a positive operating cash flow in the past year.
  • In the past 5 years QGEN has always been profitable.
  • QGEN had a positive operating cash flow in each of the past 5 years.
QGEN Yearly Net Income VS EBIT VS OCF VS FCFQGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • QGEN has a better Return On Assets (6.75%) than 82.46% of its industry peers.
  • QGEN has a better Return On Equity (11.25%) than 82.46% of its industry peers.
  • QGEN has a better Return On Invested Capital (7.23%) than 78.95% of its industry peers.
Industry RankSector Rank
ROA 6.75%
ROE 11.25%
ROIC 7.23%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QGEN Yearly ROA, ROE, ROICQGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 20.33%, QGEN belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
  • QGEN's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 25.69%, QGEN belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
  • QGEN's Operating Margin has declined in the last couple of years.
  • QGEN has a Gross Margin of 62.97%. This is amongst the best in the industry. QGEN outperforms 84.21% of its industry peers.
  • In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
Industry RankSector Rank
OM 25.69%
PM (TTM) 20.33%
GM 62.97%
OM growth 3Y-2.56%
OM growth 5Y-2.83%
PM growth 3Y0.95%
PM growth 5Y1.14%
GM growth 3Y-1.29%
GM growth 5Y-1.16%
QGEN Yearly Profit, Operating, Gross MarginsQGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. QGEN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QGEN is destroying value.
  • There is no outstanding debt for QGEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QGEN Yearly Shares OutstandingQGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QGEN Yearly Total Debt VS Total AssetsQGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.47 indicates that QGEN is not in any danger for bankruptcy at the moment.
  • QGEN's Altman-Z score of 3.47 is fine compared to the rest of the industry. QGEN outperforms 71.93% of its industry peers.
  • The Debt to FCF ratio of QGEN is 3.70, which is a good value as it means it would take QGEN, 3.70 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.70, QGEN is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
  • QGEN has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of QGEN (0.44) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.7
Altman-Z 3.47
ROIC/WACC0.84
WACC8.6%
QGEN Yearly LT Debt VS Equity VS FCFQGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • QGEN has a Current Ratio of 3.90. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
  • QGEN's Current ratio of 3.90 is fine compared to the rest of the industry. QGEN outperforms 64.91% of its industry peers.
  • QGEN has a Quick Ratio of 3.31. This indicates that QGEN is financially healthy and has no problem in meeting its short term obligations.
  • QGEN's Quick ratio of 3.31 is fine compared to the rest of the industry. QGEN outperforms 64.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.9
Quick Ratio 3.31
QGEN Yearly Current Assets VS Current LiabilitesQGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. QGEN Growth Analysis

3.1 Past

  • QGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.63%, which is quite good.
  • The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
  • QGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.65%.
  • QGEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.25% yearly.
EPS 1Y (TTM)10.63%
EPS 3Y-0.54%
EPS 5Y1.64%
EPS Q2Q%1.64%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y-0.81%
Revenue growth 5Y2.25%
Sales Q2Q%3.69%

3.2 Future

  • QGEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.28% yearly.
  • QGEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.75% yearly.
EPS Next Y5.2%
EPS Next 2Y7.62%
EPS Next 3Y8.36%
EPS Next 5Y7.28%
Revenue Next Year6.7%
Revenue Next 2Y6.18%
Revenue Next 3Y6.14%
Revenue Next 5Y7.75%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
QGEN Yearly Revenue VS EstimatesQGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QGEN Yearly EPS VS EstimatesQGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. QGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.17 indicates a correct valuation of QGEN.
  • Based on the Price/Earnings ratio, QGEN is valued cheaper than 89.47% of the companies in the same industry.
  • QGEN is valuated rather cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 15.35 indicates a correct valuation of QGEN.
  • 87.72% of the companies in the same industry are more expensive than QGEN, based on the Price/Forward Earnings ratio.
  • QGEN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 16.17
Fwd PE 15.35
QGEN Price Earnings VS Forward Price EarningsQGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 89.47% of the companies in the same industry are more expensive than QGEN, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of QGEN indicates a rather cheap valuation: QGEN is cheaper than 85.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.4
EV/EBITDA 11.67
QGEN Per share dataQGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • QGEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.11
PEG (5Y)9.88
EPS Next 2Y7.62%
EPS Next 3Y8.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. QGEN Dividend Analysis

5.1 Amount

  • QGEN has a yearly dividend return of 0.65%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.11, QGEN pays a better dividend. On top of this QGEN pays more dividend than 94.74% of the companies listed in the same industry.
  • With a Dividend Yield of 0.65, QGEN pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

  • QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
QGEN Yearly Dividends per shareQGEN Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • QGEN pays out 12.77% of its income as dividend. This is a sustainable payout ratio.
DP12.77%
EPS Next 2Y7.62%
EPS Next 3Y8.36%
QGEN Yearly Income VS Free CF VS DividendQGEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M
QGEN Dividend Payout.QGEN Dividend Payout, showing the Payout Ratio.QGEN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

QGEN Fundamentals: All Metrics, Ratios and Statistics

QIAGEN N.V.

NYSE:QGEN (3/20/2026, 8:18:24 PM)

After market: 39.93 0 (0%)

39.93

-0.72 (-1.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-05
Inst Owners74.12%
Inst Owner Change-99.66%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.23B
Revenue(TTM)2.09B
Net Income(TTM)424.88M
Analysts71.67
Price Target55.35 (38.62%)
Short Float %3.33%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP12.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.46%
Min EPS beat(2)-3.03%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)1.12%
Min EPS beat(4)-3.03%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.49%
EPS beat(12)7
Avg EPS beat(12)1.45%
EPS beat(16)11
Avg EPS beat(16)3.7%
Revenue beat(2)0
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.31%
Revenue beat(4)1
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.72%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)1
Avg Revenue beat(12)-0.7%
Revenue beat(16)5
Avg Revenue beat(16)-0.05%
PT rev (1m)1.17%
PT rev (3m)7.13%
EPS NQ rev (1m)-3.35%
EPS NQ rev (3m)-5.36%
EPS NY rev (1m)-3.43%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)-1.57%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)0.4%
Revenue NY rev (3m)0.53%
Valuation
Industry RankSector Rank
PE 16.17
Fwd PE 15.35
P/S 3.94
P/FCF 18.4
P/OCF 12.58
P/B 2.18
P/tB 11.91
EV/EBITDA 11.67
EPS(TTM)2.47
EY6.19%
EPS(NY)2.6
Fwd EY6.51%
FCF(TTM)2.17
FCFY5.43%
OCF(TTM)3.18
OCFY7.95%
SpS10.14
BVpS18.33
TBVpS3.35
PEG (NY)3.11
PEG (5Y)9.88
Graham Number31.92
Profitability
Industry RankSector Rank
ROA 6.75%
ROE 11.25%
ROCE 9.28%
ROIC 7.23%
ROICexc 8.92%
ROICexgc 26.15%
OM 25.69%
PM (TTM) 20.33%
GM 62.97%
FCFM 21.4%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.56%
OM growth 5Y-2.83%
PM growth 3Y0.95%
PM growth 5Y1.14%
GM growth 3Y-1.29%
GM growth 5Y-1.16%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.7
Debt/EBITDA 2.26
Cap/Depr 106.91%
Cap/Sales 9.91%
Interest Coverage 250
Cash Conversion 89.55%
Profit Quality 105.25%
Current Ratio 3.9
Quick Ratio 3.31
Altman-Z 3.47
F-Score6
WACC8.6%
ROIC/WACC0.84
Cap/Depr(3y)90.15%
Cap/Depr(5y)87.64%
Cap/Sales(3y)8.95%
Cap/Sales(5y)8.6%
Profit Quality(3y)264.36%
Profit Quality(5y)202.24%
High Growth Momentum
Growth
EPS 1Y (TTM)10.63%
EPS 3Y-0.54%
EPS 5Y1.64%
EPS Q2Q%1.64%
EPS Next Y5.2%
EPS Next 2Y7.62%
EPS Next 3Y8.36%
EPS Next 5Y7.28%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y-0.81%
Revenue growth 5Y2.25%
Sales Q2Q%3.69%
Revenue Next Year6.7%
Revenue Next 2Y6.18%
Revenue Next 3Y6.14%
Revenue Next 5Y7.75%
EBIT growth 1Y8.48%
EBIT growth 3Y-3.35%
EBIT growth 5Y-0.65%
EBIT Next Year39.63%
EBIT Next 3Y17.72%
EBIT Next 5Y11.87%
FCF growth 1Y-10.97%
FCF growth 3Y-7.55%
FCF growth 5Y23.83%
OCF growth 1Y-2.85%
OCF growth 3Y-2.92%
OCF growth 5Y7.4%

QIAGEN N.V. / QGEN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for QIAGEN N.V.?

ChartMill assigns a fundamental rating of 6 / 10 to QGEN.


Can you provide the valuation status for QIAGEN N.V.?

ChartMill assigns a valuation rating of 6 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.


What is the profitability of QGEN stock?

QIAGEN N.V. (QGEN) has a profitability rating of 7 / 10.


What is the earnings growth outlook for QIAGEN N.V.?

The Earnings per Share (EPS) of QIAGEN N.V. (QGEN) is expected to grow by 5.2% in the next year.


Can you provide the dividend sustainability for QGEN stock?

The dividend rating of QIAGEN N.V. (QGEN) is 3 / 10 and the dividend payout ratio is 12.77%.